Maximus Stock Forecast, Price & News

Maximus (NYSE:MMS) Frequently Asked Questions

Is Maximus a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Maximus in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Maximus stock.
View analyst ratings for Maximus or view top-rated stocks.

How has Maximus' stock price been impacted by COVID-19?

Maximus' stock was trading at $60.94 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MMS stock has increased by 28.6% and is now trading at $78.38.
View which stocks have been most impacted by COVID-19.

When is Maximus' next earnings date?

Maximus is scheduled to release its next quarterly earnings announcement on Thursday, February 3rd 2022.
View our earnings forecast for Maximus.

How were Maximus' earnings last quarter?

Maximus, Inc. (NYSE:MMS) announced its quarterly earnings data on Thursday, November, 18th. The health services provider reported $1.08 earnings per share for the quarter, beating the consensus estimate of $0.87 by $0.21. The health services provider earned $1.11 billion during the quarter, compared to the consensus estimate of $1.08 billion. Maximus had a net margin of 6.84% and a trailing twelve-month return on equity of 22.53%. The company's quarterly revenue was up 19.7% on a year-over-year basis. During the same period in the previous year, the company posted $1.02 EPS.
View Maximus' earnings history.

How often does Maximus pay dividends? What is the dividend yield for Maximus?

Maximus declared a quarterly dividend on Thursday, October 14th. Shareholders of record on Monday, November 15th will be paid a dividend of $0.28 per share on Tuesday, November 30th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.43%. The ex-dividend date is Friday, November 12th.
View Maximus' dividend history.

Is Maximus a good dividend stock?

Maximus pays an annual dividend of $1.12 per share and currently has a dividend yield of 1.44%. The dividend payout ratio of Maximus is 24.03%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Maximus will have a dividend payout ratio of 20.14% next year. This indicates that Maximus will be able to sustain or increase its dividend.
View Maximus' dividend history.

What guidance has Maximus issued on next quarter's earnings?

Maximus issued an update on its FY 2022 earnings guidance on Thursday, December, 2nd. The company provided EPS guidance of $5.070-$5.370 for the period, compared to the Thomson Reuters consensus estimate of $4.450. The company issued revenue guidance of $4.40 billion-$4.60 billion, compared to the consensus revenue estimate of $4.12 billion.

What price target have analysts set for MMS?

2 equities research analysts have issued 12 month price objectives for Maximus' shares. Their forecasts range from $95.00 to $105.00. On average, they expect Maximus' stock price to reach $100.00 in the next year. This suggests a possible upside of 27.6% from the stock's current price.
View analysts' price targets for Maximus or view top-rated stocks among Wall Street analysts.

Who are Maximus' key executives?

Maximus' management team includes the following people:

• Bruce L. Caswell, Co-President, Chief Executive Officer & Director
• Manish Agarwal, Co-President
• Richard J. Nadeau, Chief Financial Officer & Treasurer
• Michael S. Weiner, Chief Medical Officer
• John W. Lambeth, Chief Information Officer

What is Bruce Caswell's approval rating as Maximus' CEO?

145 employees have rated Maximus CEO Bruce Caswell on Glassdoor.com. Bruce Caswell has an approval rating of 80% among Maximus' employees.

Who are some of Maximus' key competitors?

Some companies that are related to Maximus include Visa (V), Mastercard (MA), Automatic Data Processing (ADP), Fiserv (FISV), Fidelity National Information Services (FIS), Paychex (PAYX), Global Payments (GPN), Broadridge Financial Solutions (BR), FLEETCOR Technologies (FLT), Jack Henry & Associates (JKHY), Genpact (G), Western Union (WU), Euronet Worldwide (EEFT), WEX (WEX) and ExlService (EXLS).
View all of MMS's competitors.

What other stocks do shareholders of Maximus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Maximus investors own include Pfizer (PFE), Lennar (LEN), AbbVie (ABBV), Cisco Systems (CSCO), Kroger (KR), Skyworks Solutions (SWKS), Advanced Micro Devices (AMD), Cerner (CERN), Intel (INTC) and JD.com (JD).

What is Maximus' stock symbol?

Maximus trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

Who are Maximus' major shareholders?

Maximus' stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (12.47%), Victory Capital Management Inc. (6.87%), Alliancebernstein L.P. (5.12%), Mackenzie Financial Corp (4.23%), Mondrian Investment Partners LTD (2.44%) and Janus Henderson Group PLC (2.03%). Company insiders that own Maximus stock include Bruce Caswell, David Francis, Ilene R Baylinson, Michelle F Link, Peter Pond, Raymond B Ruddy, Richard A Montoni, Richard John Nadeau and Thomas D Romeo.
View institutional ownership trends for Maximus.

Which major investors are selling Maximus stock?

MMS stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Boston Partners, Raymond James & Associates, Renaissance Technologies LLC, Citadel Advisors LLC, Handelsbanken Fonder AB, Man Group plc, and AXA S.A.. Company insiders that have sold Maximus company stock in the last year include David Francis, Ilene R Baylinson, Michelle F Link, Peter Pond, Raymond B Ruddy, Richard A Montoni, Richard John Nadeau, and Thomas D Romeo.
View insider buying and selling activity for Maximus or view top insider-selling stocks.

Which major investors are buying Maximus stock?

MMS stock was bought by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Alliancebernstein L.P., Mackenzie Financial Corp, Robeco Schweiz AG, Goldman Sachs Group Inc., Nordea Investment Management AB, 12th Street Asset Management Company LLC, and Mondrian Investment Partners LTD.
View insider buying and selling activity for Maximus or or view top insider-buying stocks.

How do I buy shares of Maximus?

Shares of MMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Maximus' stock price today?

One share of MMS stock can currently be purchased for approximately $78.38.

How much money does Maximus make?

Maximus has a market capitalization of $4.86 billion and generates $4.25 billion in revenue each year. The health services provider earns $291.20 million in net income (profit) each year or $4.66 on an earnings per share basis.

How many employees does Maximus have?

Maximus employs 35,800 workers across the globe.

When was Maximus founded?

Maximus was founded in 1975.

What is Maximus' official website?

The official website for Maximus is www.maximus.com.

Where are Maximus' headquarters?

Maximus is headquartered at 1891 METRO CENTER DRIVE, RESTON VA, 20190.

How can I contact Maximus?

Maximus' mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The health services provider can be reached via phone at (703) 251-8500, via email at [email protected], or via fax at 703-251-8240.